✦ LIBER ✦

Bromocriptine in the treatment of hypertension

✍ Scribed by R. J. Walden; J. Hernandez; P. Bhattacharjee; B. Graham; B. N. C. Prichard

Publisher: Springer
Year: 1986
Tongue: English
Weight: 581 KB
Volume: 30
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00614291

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bromocriptin treatment of psoriasis

✍ J. J. Guilhou; E. Guilhou 📂 Article 📅 1982 🏛 Springer-Verlag 🌐 English ⚖ 109 KB

Treatment of psoriasis with bromocriptin

✍ G. Weber; M. Neidhardt; H. Frey; K. Galle; A. Geiger 📂 Article 📅 1981 🏛 Springer-Verlag 🌐 English ⚖ 165 KB

Sixty patients suffering from psoriasis of all clinical forms have been treated with an increased dosage of Bromocriptin. The age of the patients ranged from 20 to 72 years. Patients with contraindications for Bromocriptin were excluded from the test. In 80% a remission or reduction of psoriasis les

Treatment of hypertension in the elderly

✍ W. H. Birkenhäger; P. W. Leeuw; A. Amery; J. Staessen 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 408 KB

## Veterans' Administration Co-operative Group W hen the causes of chronic morbidity and disability in people beyond middle age are analyzed it is obvious that cerebrovascular and cardiac ailments are the main contributors. Among the quantifiable risk factors for these disorders in older people hi

Nifedipine in the treatment of hypertens

Nifedipine in the treatment of hypertension

✍ F. Brennan; M. Flanagan; S. Blake; P. Cannon 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 401 KB

Treatment of hypertension

✍ Koenig, W. ;Keil, U. ;Perz, S. ;Stieber, J. ;Döring, A. 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 1002 KB

A crossover trial of bromocriptine in th

A crossover trial of bromocriptine in the treatment of vascular dementia

✍ Dr. Stephen E. Nadeau; Paul F. Malloy; Michael E. Andrew 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB 👁 2 views

Seven patients with vascular dementia completed an 8month randomized double-blind crossover trial of bromocriptine i n a dosage of u p to 30 mg per day. Patients were assessed using a modified UCLA Parkinson Rating Scale of symptoms and signs, and neuropsychological testing including the Wechsler Ad